
Lipocine (LPCN) Gets a Buy from Alliance Global Partners

I'm PortAI, I can summarize articles.
Alliance Global Partners analyst maintained a Buy rating on Lipocine today and set a price target of $6.75.Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow. Lipocine has an analyst consensus of Moderate Buy, with a price target consensus of $7.38.
Alliance Global Partners analyst maintained a Buy rating on Lipocine today and set a price target of $6.75.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Lipocine has an analyst consensus of Moderate Buy, with a price target consensus of $7.38.

